L

LegoChem Biosciences Inc
KOSDAQ:141080

Watchlist Manager
LegoChem Biosciences Inc
KOSDAQ:141080
Watchlist
Price: 211 000 KRW 0.48% Market Closed
Market Cap: ₩7.7T

Balance Sheet

Balance Sheet Decomposition
LegoChem Biosciences Inc

Balance Sheet
LegoChem Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 146
1 367
614
1 296
1 767
1 343
1 622
2 443
2 968
8 623
2 202
22 204
44 238
29 442
21 391
15 529
Cash
0
0
0
0
0
0
78
382
2 826
8 623
1 682
15 954
5 381
50
0
0
Cash Equivalents
1 146
1 367
614
1 296
1 767
1 343
1 544
2 061
142
0
520
6 250
38 857
29 393
21 391
15 529
Short-Term Investments
2 500
6 590
3 800
4 643
3 717
18 705
28 409
16 655
27 036
12 603
59 500
20 000
7 000
141 498
137 574
77 574
Total Receivables
149
73
158
80
134
806
410
9 577
13 173
15 960
26 347
57 181
32 139
46 529
19 817
20 880
Accounts Receivables
80
42
45
45
61
784
262
9 258
12 700
15 620
17 800
11 336
20 687
22 594
13 331
15 665
Other Receivables
69
31
113
35
73
22
148
319
473
340
8 547
45 845
11 452
23 934
6 486
5 215
Inventory
27
1
0
0
0
0
0
1
439
936
755
2 021
285
271
199
197
Other Current Assets
64
122
162
274
878
233
177
944
6 006
7 087
4 575
10 012
16 349
11 211
12 638
20 439
Total Current Assets
3 886
8 150
4 735
6 293
6 496
21 086
30 618
29 620
49 622
45 209
93 379
111 419
100 011
228 951
191 619
134 619
PP&E Net
256
225
188
185
201
1 200
1 159
3 491
6 866
7 846
10 275
12 144
7 618
24 432
26 492
25 424
PP&E Gross
256
225
188
185
201
1 200
1 159
3 491
6 866
7 846
10 275
12 144
7 618
24 432
26 492
25 424
Accumulated Depreciation
168
263
350
483
604
868
1 248
4 818
4 566
5 739
6 870
9 180
5 787
5 102
7 510
9 722
Intangible Assets
277
453
9
14
44
58
123
13 731
12 437
11 356
10 110
8 988
8 150
8 601
7 889
6 901
Goodwill
0
0
0
0
0
0
0
19 134
14 331
11 465
0
0
0
0
0
0
Note Receivable
90
0
22
0
0
0
0
0
100
100
100
0
0
0
96
98
Long-Term Investments
0
0
0
0
0
0
996
990
3 903
3 916
5 185
7 326
16 517
22 631
19 825
17 340
Other Long-Term Assets
22
9
35
122
183
810
860
1 473
2 292
2 346
2 638
1 600
3 618
8 619
6 610
5 119
Other Assets
0
0
0
0
0
0
0
19 134
14 331
11 465
0
0
0
0
0
0
Total Assets
4 531
N/A
8 836
+95%
4 989
-44%
6 614
+33%
6 924
+5%
23 154
+234%
33 755
+46%
68 440
+103%
89 551
+31%
82 238
-8%
121 686
+48%
141 477
+16%
135 912
-4%
293 233
+116%
252 530
-14%
189 502
-25%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
6 060
7 570
9 117
8 178
7 692
6 555
6 846
7 285
7 095
Accrued Liabilities
5
5
42
51
50
68
95
126
181
165
136
364
222
418
3 879
11 376
Short-Term Debt
0
0
0
0
0
0
0
1 800
0
0
0
0
0
0
2 700
11 847
Current Portion of Long-Term Debt
0
2 573
20
20
20
0
0
0
6 174
6 704
0
111
78
2 858
9 333
269
Other Current Liabilities
377
593
459
651
1 757
1 826
832
1 200
1 076
1 655
1 632
7 257
7 154
6 897
5 407
6 485
Total Current Liabilities
383
3 171
521
721
1 827
1 894
927
9 186
15 001
17 640
9 946
15 424
14 009
17 018
28 603
37 072
Long-Term Debt
2 469
85
4 061
45
25
1 051
9 069
9 829
7 853
8 519
0
2 074
3 909
9 410
216
528
Deferred Income Tax
0
0
0
0
0
0
1 025
3 935
3 922
3 357
2 414
2 881
1 253
3 928
1 129
0
Minority Interest
0
0
0
0
0
0
0
0
0
1 259
3 630
2 160
0
0
0
0
Other Liabilities
434
798
1 875
1 713
1 718
2 125
2 691
2 312
2 714
3 257
4 032
5 189
4 615
4 103
2 983
3 681
Total Liabilities
3 286
N/A
4 054
+23%
6 457
+59%
2 480
-62%
3 570
+44%
5 070
+42%
13 712
+170%
25 262
+84%
29 490
+17%
34 032
+15%
20 021
-41%
27 728
+38%
23 786
-14%
34 459
+45%
32 932
-4%
41 281
+25%
Equity
Common Stock
1 155
1 436
1 291
1 786
2 762
3 567
3 828
4 522
4 971
4 977
5 999
6 004
12 053
13 624
13 834
14 211
Retained Earnings
3 054
3 479
7 472
10 665
13 449
19 560
28 434
36 671
51 441
64 289
90 294
78 812
86 138
109 586
105 383
30 740
Additional Paid In Capital
3 145
6 825
4 712
13 013
14 041
34 077
44 649
75 327
106 530
107 518
185 492
186 652
183 136
349 792
93 881
97 523
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
3 075
2 446
1 789
2 273
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4 879
Other Equity
0
0
0
0
0
0
0
0
0
0
468
95
0
2 500
4 712
8 353
Total Equity
1 246
N/A
4 782
+284%
1 468
N/A
4 134
N/A
3 354
-19%
18 084
+439%
20 044
+11%
43 178
+115%
60 060
+39%
48 206
-20%
101 665
+111%
113 749
+12%
112 126
-1%
258 775
+131%
219 599
-15%
148 221
-33%
Total Liabilities & Equity
4 531
N/A
8 836
+95%
4 989
-44%
6 614
+33%
6 924
+5%
23 154
+234%
33 755
+46%
68 440
+103%
89 551
+31%
82 238
-8%
121 686
+48%
141 477
+16%
135 912
-4%
293 233
+116%
252 530
-14%
189 502
-25%
Shares Outstanding
Common Shares Outstanding
7
7
8
8
9
14
15
18
20
20
21
21
24
24
26
28
Preferred Shares Outstanding
1
1
1
1
1
0
0
0
0
0
1
1
0
3
2
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett